Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
Provided By GlobeNewswire
Last update: May 9, 2024
Closed an oversubscribed $95 million equity financing in March with Q1 2024 cash balance of $195.1 million at quarter-end, expected to provide runway into 2027
Completed in-license agreement with Cornell University for intellectual property rights, including current and future clinical data from an ongoing investigator-initiated trial of AAVrh.10hFXN (LX2006) to support regulatory discussions
Read more at globenewswire.comNASDAQ:LXEO (4/22/2025, 3:52:40 PM)
3.405
+0.19 (+6.07%)
Find more stocks in the Stock Screener
LXEO Latest News and Analysis
13 days ago - ChartmillWhich stocks are moving on Wednesday?Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.
15 days ago - ChartmillWhich stocks are moving on Monday?Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
15 days ago - ChartmillKeep an eye on the top gainers and losers in Monday's session.Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.
15 days ago - ChartmillMonday's session: gap up and gap down stocksThe market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
